TapewireFind a company

person · Reporting owner

Don Wright

Disclosed activity across 1 company

Tapewire entity
35952
SEC CIK
0001405212

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
International Stem Cell CORPISCO · Entity 8432DirectorJune 11, 2026June 24, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

International Stem Cell CORP

Report date June 11, 2026 · Filed June 24, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.17 · Expires 2036-06-11Direct30,000 Reported balance After 2026-06-11 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2026-06-11 · Grant · Acquired 30,000 · Balance 30,000

F1: The shares underlying such option shall vest on the earlier of (a) June 11, 2027, or (b) the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant.

Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.18 · Expires 2036-06-11Direct182,584 Reported balance After 2026-06-11 transaction · row 2 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 2 · 2026-06-11 · Grant · Acquired 182,584 · Balance 182,584

F2: The shares underlying such option shall vest in equal quarterly increments through June 11, 2027, with the first increment vesting on September 11, 2026.

Filing footnotes · ownership attribution and instrument terms

F1: The shares underlying such option shall vest on the earlier of (a) June 11, 2027, or (b) the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant.

F2: The shares underlying such option shall vest in equal quarterly increments through June 11, 2027, with the first increment vesting on September 11, 2026.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
June 11, 2026 Filed Jun 24, 2026 00:31 UTC International Stem Cell CORP ISCO · Entity 8432 GrantStock Option (Right to Buy) · Derivative 182,584 $0.00 Strike: $0.18 $0.00
Disclosure

SEC source: 0001683168-26-005075 · ownership.xml · derivative · entry 2

Don Wright · CIK 0001405212 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 182,584

Underlying: Common Stock · 182,584 shares

Expires 2036-06-11

F2 · derivative.exercise_date: The shares underlying such option shall vest in equal quarterly increments through June 11, 2027, with the first increment vesting on September 11, 2026.

Read SEC document
June 11, 2026 Filed Jun 24, 2026 00:31 UTC International Stem Cell CORP ISCO · Entity 8432 GrantStock Option (Right to Buy) · Derivative 30,000 $0.00 Strike: $0.17 $0.00
Disclosure

SEC source: 0001683168-26-005075 · ownership.xml · derivative · entry 1

Don Wright · CIK 0001405212 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2036-06-11

F1 · derivative.exercise_date: The shares underlying such option shall vest on the earlier of (a) June 11, 2027, or (b) the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant.

Read SEC document
June 17, 2025 Filed Jun 20, 2025 12:21 UTC International Stem Cell CORP ISCO · Entity 8432 GrantStock Option (Right to Buy) · Derivative 532,786 $0.00 Strike: $0.13 $0.00
Disclosure

SEC source: 0001683168-25-004622 · ownership.xml · derivative · entry 2

Don Wright · CIK 0001405212 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 532,786

Underlying: Common Stock · 532,786 shares

Expires 2035-06-17

F2 · derivative.exercise_date: The shares underlying such option shall vest in equal quarterly increments through June 17, 2026, with the first increment vesting on September 17, 2025.

Read SEC document
June 17, 2025 Filed Jun 20, 2025 12:21 UTC International Stem Cell CORP ISCO · Entity 8432 GrantStock Option (Right to Buy) · Derivative 30,000 $0.00 Strike: $0.13 $0.00
Disclosure

SEC source: 0001683168-25-004622 · ownership.xml · derivative · entry 1

Don Wright · CIK 0001405212 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2035-06-17

F1 · derivative.exercise_date: The shares underlying such option shall vest on the earlier of (a) June 17, 2026, or (b) the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant.

Read SEC document
June 11, 2024 Filed Jun 13, 2024 20:05 UTC International Stem Cell CORP ISCO.OB · Entity 8432 GrantStock Option (Right to Buy) · Derivative 361,111 $0.00 Strike: $0.12 $0.00
Disclosure

SEC source: 0001683168-24-004179 · ownership.xml · derivative · entry 2

Don Wright · CIK 0001405212 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 361,111

Underlying: Common Stock · 361,111 shares

Expires 2034-06-11

F2 · derivative.exercise_date: Options shall vest in four equal quarterly increments, beginning September 11, 2024.

Read SEC document
June 11, 2024 Filed Jun 13, 2024 20:05 UTC International Stem Cell CORP ISCO.OB · Entity 8432 GrantStock Option (Right to Buy) · Derivative 30,000 $0.00 Strike: $0.12 $0.00
Disclosure

SEC source: 0001683168-24-004179 · ownership.xml · derivative · entry 1

Don Wright · CIK 0001405212 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2034-06-11

F1 · derivative.exercise_date: Options shall vest on the earlier of (i) June 11, 2025 or (ii) the date of the 2025 Annual Meeting of Stockholders.

Read SEC document
June 14, 2023 Filed Jun 16, 2023 21:23 UTC International Stem Cell CORP ISCO.OB · Entity 8432 GrantStock Option (Right to Buy) · Derivative 445,205 $0.00 Strike: $0.14 $0.00
Disclosure

SEC source: 0001683168-23-004228 · ownership.xml · derivative · entry 2

Don Wright · CIK 0001405212 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 445,205

Underlying: Common Stock · 445,205 shares

Expires 2033-06-14

F2 · derivative.exercise_date: Options vest in four equal quarterly increments, beginning 09/14/2023.

Read SEC document
June 14, 2023 Filed Jun 16, 2023 21:23 UTC International Stem Cell CORP ISCO.OB · Entity 8432 GrantStock Option (Right to Buy) · Derivative 30,000 $0.00 Strike: $0.14 $0.00
Disclosure

SEC source: 0001683168-23-004228 · ownership.xml · derivative · entry 1

Don Wright · CIK 0001405212 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2033-06-14

F1 · derivative.exercise_date: Options vest fully at the earlier of (i) 06/14/2024 or (ii) the date of the 2024 Annual Meeting of Stockholders.

Read SEC document
June 09, 2022 Filed Jun 10, 2022 21:01 UTC International Stem Cell CORP ISCO.OB · Entity 8432 GrantStock Option (Right to Buy) · Derivative 30,000 $0.00 Strike: $0.47 $0.00
Disclosure

SEC source: 0001683168-22-004288 · ownership.xml · derivative · entry 2

Don Wright · CIK 0001405212 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2032-06-09

F2 · derivative.exercise_date: Stock option granted as part of compensation for non-employee directors. Options vest fully at the earlier of (i) 06/09/2023 or (ii) the date of the 2023 Annual Meeting of Stockholders.

Read SEC document
June 09, 2022 Filed Jun 10, 2022 21:01 UTC International Stem Cell CORP ISCO.OB · Entity 8432 GrantStock Option (Right to Buy) · Derivative 139,264 $0.00 Strike: $0.47 $0.00
Disclosure

SEC source: 0001683168-22-004288 · ownership.xml · derivative · entry 1

Don Wright · CIK 0001405212 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 139,264

Underlying: Common Stock · 139,264 shares

Expires 2032-06-09

F1 · derivative.exercise_date: Stock option granted as part of compensation for non-employee directors. Options vest in four equal quarterly increments, beginning 09/09/2022.

Read SEC document
June 09, 2021 Filed Jun 11, 2021 18:12 UTC International Stem Cell CORP ISCO.OB · Entity 8432 GrantStock Option (Right to Buy) · Derivative 30,000 $0.00 Strike: $0.39 $0.00
Disclosure

SEC source: 0001683168-21-002471 · ownership.xml · derivative · entry 2

Don Wright · CIK 0001405212 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2031-06-09

F2 · derivative.exercise_date: Stock option granted as part of compensation for non-employee directors. Options vest fully at the earlier of (i) June 09, 2022 or (ii) the date of the 2022 Annual Meeting of Stockholders, with vesting accelerated for all shares in the event of a change in control.

Read SEC document
June 09, 2021 Filed Jun 11, 2021 18:12 UTC International Stem Cell CORP ISCO.OB · Entity 8432 GrantStock Option (Right to Buy) · Derivative 183,481 $0.00 Strike: $0.39 $0.00
Disclosure

SEC source: 0001683168-21-002471 · ownership.xml · derivative · entry 1

Don Wright · CIK 0001405212 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 183,481

Underlying: Common Stock · 183,481 shares

Expires 2031-06-09

F1 · derivative.exercise_date: Stock option granted as part of compensation for non-employee directors. Options vest in four equal quarterly increments, beginning 9/09/2021.

Read SEC document
June 23, 2020 Filed Jun 24, 2020 20:43 UTC International Stem Cell CORP ISCO.OB · Entity 8432 GrantStock Option (Right to Buy) · Derivative 30,000 $0.00 Strike: $1.08 $0.00
Disclosure

SEC source: 0001683168-20-002056 · ownership.xml · derivative · entry 2

Don Wright · CIK 0001405212 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2030-06-23

F2 · derivative.exercise_date: Stock option granted as part of compensation for non-employee directors. Options vest fully at the earlier of (i) June 23, 2021 or (ii) the date of the 2021 Annual Meeting of Stockholders, with vesting accelerated for all shares in the event of a change in control.

Read SEC document
June 23, 2020 Filed Jun 24, 2020 20:43 UTC International Stem Cell CORP ISCO.OB · Entity 8432 GrantStock Option (Right to Buy) · Derivative 46,428 $0.00 Strike: $1.08 $0.00
Disclosure

SEC source: 0001683168-20-002056 · ownership.xml · derivative · entry 1

Don Wright · CIK 0001405212 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,428

Underlying: Common Stock · 46,428 shares

Expires 2030-06-23

F1 · derivative.exercise_date: Stock option granted as part of compensation for non-employee directors. Options vest in four equal quarterly increments, with first increment vesting on 9/23/2020.

Read SEC document
June 23, 2020 Filed Jun 26, 2020 22:06 UTC Amendment International Stem Cell CORP ISCO.OB · Entity 8432 GrantStock Option (Right to Buy) · Derivative 92,857 $0.00 Strike: $1.08 $0.00
Disclosure

SEC source: 0001683168-20-002091 · ownership.xml · derivative · entry 1

Don Wright · CIK 0001405212 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 92,857

Underlying: Common Stock · 92,857 shares

Expires 2030-06-23

F1 · derivative.exercise_date: Stock option granted as part of compensation for non-employee directors. Options vest in four equal quarterly increments, beginning 9/23/2020.

Read SEC document
June 03, 2019 Filed Jun 5, 2019 17:47 UTC International Stem Cell CORP ISCO.OB · Entity 8432 GrantStock Option (Right to Buy) · Derivative 30,000 $0.00 Strike: $1.08 $0.00
Disclosure

SEC source: 0001683168-19-001800 · ownership.xml · derivative · entry 2

Don Wright · CIK 0001405212 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2019-06-03

F2 · derivative.exercise_date: Stock option granted as part of compensation for non-employee directors. Options vest fully at the earlier of (i) June 3, 2020 or (ii) the date of the 2020 Annual Meeting of Stockholders, with vesting accelerated for all shares in the event of a change in control.

Read SEC document
June 03, 2019 Filed Jun 5, 2019 17:47 UTC International Stem Cell CORP ISCO.OB · Entity 8432 GrantStock Option (Right to Buy) · Derivative 71,982 $0.00 Strike: $1.08 $0.00
Disclosure

SEC source: 0001683168-19-001800 · ownership.xml · derivative · entry 1

Don Wright · CIK 0001405212 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 71,982

Underlying: Common Stock · 71,982 shares

Expires 2019-06-03

F1 · derivative.exercise_date: Stock option granted as part of compensation for non-employee directors. Options vest in four equal quarterly increments, with first increment vesting on 9/03/2019.

Read SEC document
June 21, 2018 Filed Jun 25, 2018 20:19 UTC International Stem Cell CORP ISCO.OB · Entity 8432 GrantStock Options (Right to Buy) · Derivative 30,000 $0.00 Strike: $1.66 $0.00
Disclosure

SEC source: 0001683168-18-001779 · ownership.xml · derivative · entry 3

Don Wright · CIK 0001405212 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2028-06-21

F3 · derivative.exercise_date: Stock option granted as part of compensation for non-employee directors. Options vest fully at the earlier of (i) June 21, 2019 or (ii) the date of the 2019 Annual Meeting of Stockholders, with vesting accelerated for all shares in the event of a change in control.

Read SEC document
June 21, 2018 Filed Jun 25, 2018 20:19 UTC International Stem Cell CORP ISCO.OB · Entity 8432 GrantStock Options (Right to Buy) · Derivative 38,462 $0.00 Strike: $1.66 $0.00
Disclosure

SEC source: 0001683168-18-001779 · ownership.xml · derivative · entry 2

Don Wright · CIK 0001405212 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,462

Underlying: Common Stock · 38,462 shares

Expires 2028-06-21

F2 · derivative.exercise_date: Stock option granted as part of compensation for non-employee directors. Options vest in four equal quarterly increments, beginning 9/21/2018.

Read SEC document
June 21, 2018 Filed Jun 25, 2018 20:19 UTC International Stem Cell CORP ISCO.OB · Entity 8432 GrantStock Options (Right to Buy) · Derivative 8,655 $0.00 Strike: $1.66 $0.00
Disclosure

SEC source: 0001683168-18-001779 · ownership.xml · derivative · entry 1

Don Wright · CIK 0001405212 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,655

Underlying: Common Stock · 8,655 shares

Expires 2028-06-21

F1 · derivative.exercise_date: Stock option granted as part of compensation for non-employee directors. Options vest fully at time of grant.

Read SEC document
March 30, 2018 Filed Apr 3, 2018 22:37 UTC International Stem Cell CORP ISCO.OB · Entity 8432 GrantStock Option (Right to Buy) · Derivative 11,054 $0.00 Strike: $1.47 $0.00
Disclosure

SEC source: 0001683168-18-000919 · wright_frm4.xml · derivative · entry 1

Don Wright · CIK 0001405212 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,054

Underlying: Common Stock · 11,054 shares

Expires 2028-03-30

F1 · derivative.exercise_date: Stock option granted as part of compensation for non-employee directors. Options vest fully at time of grant. Q1 2018.

Read SEC document
December 29, 2017 Filed Jan 2, 2018 22:19 UTC International Stem Cell CORP ISCO.OB · Entity 8432 GrantStock Option (Right to Buy) · Derivative 10,350 $0.00 Strike: $1.60 $0.00
Disclosure

SEC source: 0001683168-18-000018 · wright_f4.xml · derivative · entry 1

Don Wright · CIK 0001405212 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,350

Underlying: Common Stock · 10,350 shares

Expires 2027-12-29

F1 · derivative.exercise_date: Common Stock granted as part of compensation for non-employee directors, with vesting at the time of grant: Q4 2017.

Read SEC document
December 12, 2017 Filed Dec 12, 2017 19:59 UTC International Stem Cell CORP ISCO.OB · Entity 8432 SaleCommon Stock 4,000 $1.50 $6,000.00
Disclosure

SEC source: 0001683168-17-003284 · wright_frm4.xml · nonDerivative · entry 7

Don Wright · CIK 0001405212 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,739

Read SEC document
December 11, 2017 Filed Dec 12, 2017 19:59 UTC International Stem Cell CORP ISCO.OB · Entity 8432 SaleCommon Stock 1,000 $1.50 $1,500.00
Disclosure

SEC source: 0001683168-17-003284 · wright_frm4.xml · nonDerivative · entry 6

Don Wright · CIK 0001405212 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,739

Read SEC document
December 11, 2017 Filed Dec 12, 2017 19:59 UTC International Stem Cell CORP ISCO.OB · Entity 8432 SaleCommon Stock 611 $1.50 $916.50
Disclosure

SEC source: 0001683168-17-003284 · wright_frm4.xml · nonDerivative · entry 5

Don Wright · CIK 0001405212 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,739

Read SEC document
December 11, 2017 Filed Dec 12, 2017 19:59 UTC International Stem Cell CORP ISCO.OB · Entity 8432 SaleCommon Stock 2,100 $1.50 $3,150.00
Disclosure

SEC source: 0001683168-17-003284 · wright_frm4.xml · nonDerivative · entry 4

Don Wright · CIK 0001405212 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,350

Read SEC document
December 11, 2017 Filed Dec 12, 2017 19:59 UTC International Stem Cell CORP ISCO.OB · Entity 8432 SaleCommon Stock 266 $1.50 $399.00
Disclosure

SEC source: 0001683168-17-003284 · wright_frm4.xml · nonDerivative · entry 3

Don Wright · CIK 0001405212 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,450

Read SEC document
December 08, 2017 Filed Dec 8, 2017 18:19 UTC International Stem Cell CORP ISCO.OB · Entity 8432 SaleCommon Stock 2,000 $1.50 $3,000.00
Disclosure

SEC source: 0001683168-17-003261 · wright_f4.xml · nonDerivative · entry 8

Don Wright · CIK 0001405212 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,000

Read SEC document
December 08, 2017 Filed Dec 8, 2017 18:19 UTC International Stem Cell CORP ISCO.OB · Entity 8432 SaleCommon Stock 10,000 $1.50 $15,000.00
Disclosure

SEC source: 0001683168-17-003261 · wright_f4.xml · nonDerivative · entry 7

Don Wright · CIK 0001405212 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,000

Read SEC document
December 08, 2017 Filed Dec 8, 2017 18:19 UTC International Stem Cell CORP ISCO.OB · Entity 8432 SaleCommon Stock 2,100 $1.50 $3,150.00
Disclosure

SEC source: 0001683168-17-003261 · wright_f4.xml · nonDerivative · entry 6

Don Wright · CIK 0001405212 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,000

Read SEC document
December 08, 2017 Filed Dec 12, 2017 19:59 UTC International Stem Cell CORP ISCO.OB · Entity 8432 SaleCommon Stock 700 $1.50 $1,050.00
Disclosure

SEC source: 0001683168-17-003284 · wright_frm4.xml · nonDerivative · entry 2

Don Wright · CIK 0001405212 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,716

Read SEC document
December 08, 2017 Filed Dec 12, 2017 19:59 UTC International Stem Cell CORP ISCO.OB · Entity 8432 SaleCommon Stock 2,584 $1.50 $3,876.00
Disclosure

SEC source: 0001683168-17-003284 · wright_frm4.xml · nonDerivative · entry 1

Don Wright · CIK 0001405212 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,416

Read SEC document
December 07, 2017 Filed Dec 8, 2017 18:19 UTC International Stem Cell CORP ISCO.OB · Entity 8432 SaleCommon Stock 1,039 $1.50 $1,558.50
Disclosure

SEC source: 0001683168-17-003261 · wright_f4.xml · nonDerivative · entry 5

Don Wright · CIK 0001405212 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,100

Read SEC document
December 07, 2017 Filed Dec 8, 2017 18:19 UTC International Stem Cell CORP ISCO.OB · Entity 8432 SaleCommon Stock 500 $1.50 $750.00
Disclosure

SEC source: 0001683168-17-003261 · wright_f4.xml · nonDerivative · entry 4

Don Wright · CIK 0001405212 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,139

Read SEC document
December 06, 2017 Filed Dec 8, 2017 18:19 UTC International Stem Cell CORP ISCO.OB · Entity 8432 SaleCommon Stock 2,000 $1.50 $3,000.00
Disclosure

SEC source: 0001683168-17-003261 · wright_f4.xml · nonDerivative · entry 3

Don Wright · CIK 0001405212 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,639

Read SEC document
December 06, 2017 Filed Dec 8, 2017 18:19 UTC International Stem Cell CORP ISCO.OB · Entity 8432 SaleCommon Stock 500 $1.54 $770.00
Disclosure

SEC source: 0001683168-17-003261 · wright_f4.xml · nonDerivative · entry 2

Don Wright · CIK 0001405212 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,639

Read SEC document
December 06, 2017 Filed Dec 8, 2017 18:19 UTC International Stem Cell CORP ISCO.OB · Entity 8432 SaleCommon Stock 500 $1.55 $775.00
Disclosure

SEC source: 0001683168-17-003261 · wright_f4.xml · nonDerivative · entry 1

Don Wright · CIK 0001405212 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,139

Read SEC document
September 29, 2017 Filed Oct 2, 2017 23:49 UTC International Stem Cell CORP ISCO.OB · Entity 8432 GrantStock Option (Right to Buy) · Derivative 8,830 $0.00 Strike: $1.80 $0.00
Disclosure

SEC source: 0001683168-17-002551 · wright_f4.xml · derivative · entry 1

Don Wright · CIK 0001405212 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,830

Underlying: Common Stock · 8,830 shares

Expires 2027-09-29

F1 · derivative.exercise_date: Stock option granted as part of compensation for non-employee directors. Options vest fully at time of grant: Q3 2017.

Read SEC document
June 30, 2017 Filed Jul 5, 2017 21:49 UTC International Stem Cell CORP ISCO.OB · Entity 8432 GrantStock Option (Right to Buy) · Derivative 14,254 $0.00 Strike: $1.20 $0.00
Disclosure

SEC source: 0001683168-17-001724 · wright_frm4.xml · derivative · entry 1

Don Wright · CIK 0001405212 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,254

Underlying: Common Stock · 14,254 shares

Expires 2027-06-30

F1 · derivative.exercise_date: Stock option granted as part of compensation for non-employee directors. Options vest fully at time of grant. Q2 2017

Read SEC document
May 31, 2017 Filed Jun 2, 2017 17:20 UTC International Stem Cell CORP ISCO.OB · Entity 8432 GrantStock Option (Right to Buy) · Derivative 30,000 $0.00 Strike: $1.10 $0.00
Disclosure

SEC source: 0001683168-17-001479 · wright_f4.xml · derivative · entry 1

Don Wright · CIK 0001405212 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2027-05-31

F1 · derivative.exercise_date: Stock option granted as part of compensation for non-employee directors. Options vest fully on the earlier of (i) May 31, 2018 or (ii) the date of the 2018 Annual Meeting of Stockholders, with vesting accelerated for all shares in the event of a change in control. All grants have an exercise price of $1.10 per share.

Read SEC document
March 31, 2017 Filed Apr 3, 2017 17:14 UTC International Stem Cell CORP ISCO.OB · Entity 8432 GrantCommon Stock 4,642 $0.00 $0.00
Disclosure

SEC source: 0001683168-17-000766 · wright_f4.xml · nonDerivative · entry 1

Don Wright · CIK 0001405212 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,639

F1 · security: Common Stock granted as part of compensation for non-employee directors, with vesting at the time of grant. Q1 2017.

Read SEC document
December 30, 2016 Filed Dec 30, 2016 20:00 UTC International Stem Cell CORP ISCO.OB · Entity 8432 GrantCommon Stock 7,523 $0.00 $0.00
Disclosure

SEC source: 0001683168-16-001040 · wright_f4.xml · nonDerivative · entry 1

Don Wright · CIK 0001405212 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,997

F1 · security: Common Stock granted as part of compensation for non-employee directors, with vesting at the time of grant. Q4 2016.

Read SEC document
October 13, 2016 Filed Oct 14, 2016 19:40 UTC International Stem Cell CORP ISCO.OB · Entity 8432 GrantCommon Stock 1,334 $0.00 $0.00
Disclosure

SEC source: 0001683168-16-000324 · wright_f4.xml · nonDerivative · entry 1

Don Wright · CIK 0001405212 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,474

F1 · security: Common Stock granted as part of compensation for non-employee directors (Annual Grant), with vesting at the time of grant.

Read SEC document
September 30, 2016 Filed Sep 30, 2016 20:55 UTC International Stem Cell CORP ISCO.OB · Entity 8432 GrantCommon Stock 4,391 $0.00 $0.00
Disclosure

SEC source: 0001683168-16-000228 · wright_frm4.xml · nonDerivative · entry 1

Don Wright · CIK 0001405212 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,140

F1 · security: Common Stock granted as part of compensation for non-employee directors, with vesting at the time of grant. Q3 2016.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.